MECP2 and neurodevelopmental disorder: Furthermore, dysregulation of DNA methylation is the cause of multiple neurodevelopmental disorders, including Fragile X syndrome, in which the expansion of a CGG repeat in the FMR1 promotor leads to de novo DNA methylation and silencing of gene expression (Jin and Warren, 2000), and Rett syndrome, which is caused by mutations in the transcriptional inhibitor methyl-CpG-binding protein 2 (MeCP2), which specifically binds methylated DNA (Amir et al., 1999).